Invention Grant
- Patent Title: Suture line administration technique using botulinum toxins
- Patent Title (中): 缝合线管理技术使用肉毒杆菌毒素
-
Application No.: US14086760Application Date: 2013-11-21
-
Publication No.: US09248168B2Publication Date: 2016-02-02
- Inventor: Andrew M. Blumenfeld
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Brigitte C. Phan; Ted A. Chan
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K38/48 ; A61K39/00
Abstract:
The present invention utilizes patient-specific landmarks in order to treat headache pain. In one aspect, the present invention relates to the administration of Clostridial toxins, such as a botulinum neurotoxin, to a patient suffering from a headache pain, where the location of administration of the botulinum toxin is based upon at least one suture line of the patient's skull.
Public/Granted literature
- US20140079687A1 Suture line Administration Technique using Botulinum Toxins Public/Granted day:2014-03-20
Information query
